"Schwerpunktversorgung und akademisches Lehrkrankenhaus in Mainz"

During the past decade, Katholisches Klinikum Mainz conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 4 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Katholisches Klinikum Mainz" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Pfizer" with 2 trials sponsored, "AGO Research GmbH" with 1 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored and "Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Katholisches Klinikum Mainz" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Mutualista Asociación Hospital Evangélico" with 1 trials as a collaborator, "Pallium Latinoamérica N.G.O" with 1 trials as a collaborator and "PneumRx, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Katholisches Klinikum Mainz" are "Breast Neoplasms" (2 trials), "Atrial Fibrillation" (1 trials), "Bereavement" (1 trials), "Elective Colonoscopy" (1 trials) and "Emphysema" (1 trials). Many other conditions were trialed in "Katholisches Klinikum Mainz" in a lesser frequency.

Most popular intervention types in "Katholisches Klinikum Mainz" are "Drug" (10 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Empagliflozin" (2 trials), "Apixaban" (1 trials), "Bempedoic acid and/or its fixed-dose combination with ezetimibe" (1 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Katholisches Klinikum Mainz" are 10 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Katholisches Klinikum Mainz". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Katholisches Klinikum Mainz, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Katholisches Klinikum Mainz, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".